Woteki Catherine E 4
4 · NEOGEN CORP · Filed Oct 12, 2021
Insider Transaction Report
Form 4
NEOGEN CORPNEOG
Woteki Catherine E
Director
Transactions
- Exercise/Conversion
Common Stock (Right to Buy)
2021-10-07+2,971→ 6,651 totalExercise: $42.45Exp: 2026-10-07→ Common Stock (2,971 underlying) - Exercise/Conversion
Restricted Stock Units
2021-10-07+707→ 1,273 totalExercise: $42.45Exp: 2024-10-07→ Common Stock (707 underlying)
Footnotes (2)
- [F1]Options have five year lives, and vest in three equal annual installments on each of the first three anniversary dates of the grant
- [F2]RSUs vest in three equal annual installments, on each of the first three anniversary dates of the grant